Podcasts
Listen to Avalere Health Essential Voice podcasts. Twenty years ago, we set out to be the essential voice in improving healthcare. Rest your eyes or use your commute time to hear our experts discuss the hot topics that you need to track.
Medicare Part D, Part V: What’s Next for CMMI?
Tune into the fifth and final episode of the Avalere Health Essential Voice miniseries focused on Medicare Part D. In this segment, our experts discuss the Center for Medicare & Medicaid Innovation (CMMI) and its strategic direction for the coming year, particularly as it relates to the Part D program.
Medicare Part D, Part IV: Budget Neutrality and Congressional Scoring
Tune into the fourth episode of the Avalere Health Essential Voice miniseries focused on Medicare Part D. In this segment, our experts discuss key elements of the legislative process, including pay-fors, budget neutrality, and congressional scoring.
Medicare Part D, Part III: Impact of Policy Changes on Market Access
Tune into the third episode of the Avalere Health Essential Voice miniseries focused on Medicare Part D. In this segment, our experts discuss policy changes currently under consideration and how stakeholders can prepare for the potential market access impacts.
Medicare Part D, Part II: Understanding Plan Decision-Making
Tune into the second episode of the Avalere Health Essential Voice miniseries focused on Medicare Part D. In this segment, our Policy and Market Access experts discuss how health plans make decisions, particularly formulary decisions, in Part D, and how specific markets influence those decisions.
Cell and Gene Therapy in Oncology, Part III
Tune into another episode of the Avalere Health Essential Voice podcast series focused on disease education. In this segment, the final in our series on cell and gene therapies, experts from our Market Access practice discuss the need for patient support in cell and gene therapies, and the role that manufacturers and other stakeholders can play in providing it.
Medicare Part D, Part I: Key Trends and Pressures
Tune into the first episode of the Avalere Health Essential Voice miniseries focused on Medicare Part D. In this segment, our Policy and Market Access experts discuss Part D trends and pressures in the currently evolving drug pricing environment.
What’s Next for Health Policy on Capitol Hill?
Tune into another episode of Avalere Health Essential Voice. In this segment, Avalere policy expert Matt Kazan discusses what he expects to see from a legislative perspective this fall on Capitol Hill.
The Coverage Gap and Medicaid Expansion
In this segment, our experts discuss the forthcoming debate around the coverage gap in non-Medicaid expansion states, potential policy options, and the impact on key stakeholders.
Navigating Distribution and Third-Party Logistics, Part I
In this segment, our experts welcome leaders from Jazz Pharmaceuticals and Coherus BioSciences to discuss the selection process and key learnings and considerations for working with a third-party logistics (3PL) company.
Cell and Gene Therapy in Oncology, Part II
Tune into another episode of the Avalere Health Essential Voice podcast series focused on disease education. In this segment, the second in a series focused on cell and gene therapies, experts from our Policy and Market Access practices discuss value-based payment arrangements in cell and gene therapies, and the role they play in facilitating access to these therapies.
Huntington’s Disease: Challenges and Treatment
Tune into another episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, our experts from the Center for Healthcare Transformation discuss Huntington’s Disease, its impact on caregivers, the complexities of genetic testing, and potential treatment options for this rare disorder.
Direct Contracting and Advancing Home-Based Care with Landmark Health
Tune into another episode of Start Your Day with Avalere. In this segment, Chris Johnson of Landmark Health joins Fred Bentley, Managing Director in Avalere’s Center for Healthcare Transformation, to discuss his organization’s experience as an early participant in CMMI’s Direct Contracting payment model and how value-based models can advance home-based care.
Cell and Gene Therapy in Oncology, Part I
Tune into another episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, the first of several discussing cell and gene therapies, experts from our Policy and Market Access practices highlight many of the challenges surrounding these therapies from both the patient and payer perspective.
Impacts of the ACA’s Medicaid Expansion on Women of Reproductive Age
In this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a study on the impact of Medicaid expansion on coverage and care for women of reproductive age.
Infusing the Patient Perspective into Value Assessment, Part III
Tune into another episode of Avalere Health Essential Voice in our Start Your Day with Avalere series. In the final segment of our series on infusing the patient perspective into value assessment, our experts discuss the Patient Perspective Value Framework (PPVF) developed by Avalere Health and FasterCures, which employs a form of multi-criteria decision analysis to capture value according to patients.
COVID-19 and Oncology Care
Tune into another episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, experts from Community Oncology Alliance (COA) and Texas Oncology join us to discuss the impact of COVID-19 on oncology care from a provider and patient perspective.
Healthcare Price Transparency
Tune into another episode of Avalere Health Essential Voice in our Start Your Day with Avalere series. In this segment, our policy experts discuss the topic of healthcare price transparency in terms of policy, compliance, and the potential impact of making previously confidential pricing information public.
Infusing the Patient Perspective into Value Assessment, Part II
Tune into another episode of Avalere Health Essential Voice in our Start Your Day with Avalere series. In this segment, we continue our series on infusing the patient perspective into value assessment with a discussion on the need for a solution to incorporating value drivers outside of traditional endpoints, and introduce a proposed approach to quantify those elements of healthcare value.
Oncology Care and NCCN Key Takeaways
Tune into another episode of the Avalere Health Essential Voice series focused on disease education. In this segment, our Market Access experts discuss major takeaways from the 2021 NCCN annual conference in the areas of diagnostics, holistic approaches to cancer treatment, and how the pandemic has influenced cancer care.
Infusing the Patient Perspective into Value Assessment, Part I
Tune into another episode of Avalere Health Essential Voice in our Start Your Day with Avalere series. In this segment, our experts kick off a three-part series about patient perspective in value assessment with an overview of value assessments and value frameworks.